nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—HTR2A—enteric nervous system—Crohn's disease	0.0349	0.351	CbGeAlD
Donepezil—HTR2A—myenteric nerve plexus—Crohn's disease	0.0264	0.266	CbGeAlD
Donepezil—HRH3—digestive system—Crohn's disease	0.0103	0.104	CbGeAlD
Donepezil—SIGMAR1—smooth muscle tissue—Crohn's disease	0.00476	0.0479	CbGeAlD
Donepezil—SIGMAR1—mammalian vulva—Crohn's disease	0.00428	0.0431	CbGeAlD
Donepezil—Dermatitis bullous—Mesalazine—Crohn's disease	0.00338	0.00385	CcSEcCtD
Donepezil—Delusion—Prednisone—Crohn's disease	0.00333	0.00379	CcSEcCtD
Donepezil—Arthritis—Mesalazine—Crohn's disease	0.00333	0.00379	CcSEcCtD
Donepezil—Anaemia—Mercaptopurine—Crohn's disease	0.00331	0.00378	CcSEcCtD
Donepezil—Osteoarthritis—Mesalazine—Crohn's disease	0.00323	0.00368	CcSEcCtD
Donepezil—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.00323	0.00368	CcSEcCtD
Donepezil—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00321	0.00365	CcSEcCtD
Donepezil—ACHE—lymph node—Crohn's disease	0.0032	0.0322	CbGeAlD
Donepezil—Affect lability—Mesalazine—Crohn's disease	0.00318	0.00362	CcSEcCtD
Donepezil—Glaucoma—Prednisone—Crohn's disease	0.00313	0.00356	CcSEcCtD
Donepezil—Face oedema—Mesalazine—Crohn's disease	0.00312	0.00356	CcSEcCtD
Donepezil—Mood swings—Mesalazine—Crohn's disease	0.00306	0.00349	CcSEcCtD
Donepezil—Arthralgia—Mercaptopurine—Crohn's disease	0.00305	0.00348	CcSEcCtD
Donepezil—Fungal infection—Prednisone—Crohn's disease	0.00305	0.00348	CcSEcCtD
Donepezil—Blood creatinine increased—Mesalazine—Crohn's disease	0.00303	0.00345	CcSEcCtD
Donepezil—Pancreatitis—Azathioprine—Crohn's disease	0.00301	0.00343	CcSEcCtD
Donepezil—Liver function test abnormal—Mesalazine—Crohn's disease	0.00298	0.0034	CcSEcCtD
Donepezil—Abscess—Prednisone—Crohn's disease	0.00298	0.00339	CcSEcCtD
Donepezil—Dry skin—Mesalazine—Crohn's disease	0.00296	0.00338	CcSEcCtD
Donepezil—Abdominal pain upper—Mesalazine—Crohn's disease	0.00295	0.00336	CcSEcCtD
Donepezil—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00295	0.00336	CcSEcCtD
Donepezil—Abdominal discomfort—Azathioprine—Crohn's disease	0.00294	0.00335	CcSEcCtD
Donepezil—Oedema—Mercaptopurine—Crohn's disease	0.00293	0.00333	CcSEcCtD
Donepezil—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00291	0.00332	CcSEcCtD
Donepezil—Cramp muscle—Mesalazine—Crohn's disease	0.00291	0.00332	CcSEcCtD
Donepezil—Glycosuria—Prednisone—Crohn's disease	0.00291	0.00331	CcSEcCtD
Donepezil—Nasopharyngitis—Mesalazine—Crohn's disease	0.00289	0.00329	CcSEcCtD
Donepezil—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00287	0.00327	CcSEcCtD
Donepezil—Gastritis—Mesalazine—Crohn's disease	0.00286	0.00326	CcSEcCtD
Donepezil—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00285	0.00325	CcSEcCtD
Donepezil—Abdominal distension—Mesalazine—Crohn's disease	0.00281	0.0032	CcSEcCtD
Donepezil—Asthma—Mesalazine—Crohn's disease	0.00279	0.00318	CcSEcCtD
Donepezil—Influenza—Mesalazine—Crohn's disease	0.00279	0.00318	CcSEcCtD
Donepezil—Dysphagia—Mesalazine—Crohn's disease	0.00279	0.00318	CcSEcCtD
Donepezil—Anorexia—Mercaptopurine—Crohn's disease	0.00279	0.00318	CcSEcCtD
Donepezil—Eosinophilia—Mesalazine—Crohn's disease	0.00277	0.00315	CcSEcCtD
Donepezil—Pneumonia—Azathioprine—Crohn's disease	0.00275	0.00313	CcSEcCtD
Donepezil—Pancreatitis—Mesalazine—Crohn's disease	0.00274	0.00312	CcSEcCtD
Donepezil—Infestation NOS—Azathioprine—Crohn's disease	0.00273	0.00312	CcSEcCtD
Donepezil—Infestation—Azathioprine—Crohn's disease	0.00273	0.00312	CcSEcCtD
Donepezil—Angina pectoris—Mesalazine—Crohn's disease	0.00272	0.0031	CcSEcCtD
Donepezil—Contusion—Prednisone—Crohn's disease	0.0027	0.00308	CcSEcCtD
Donepezil—Bronchitis—Mesalazine—Crohn's disease	0.00269	0.00306	CcSEcCtD
Donepezil—Abdominal discomfort—Mesalazine—Crohn's disease	0.00268	0.00305	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00267	0.00304	CcSEcCtD
Donepezil—HTR2A—epithelium—Crohn's disease	0.00263	0.0265	CbGeAlD
Donepezil—Dysuria—Mesalazine—Crohn's disease	0.00261	0.00298	CcSEcCtD
Donepezil—Arthropathy—Prednisone—Crohn's disease	0.00259	0.00295	CcSEcCtD
Donepezil—Pollakiuria—Mesalazine—Crohn's disease	0.00258	0.00294	CcSEcCtD
Donepezil—Decreased appetite—Mercaptopurine—Crohn's disease	0.00254	0.0029	CcSEcCtD
Donepezil—Weight increased—Mesalazine—Crohn's disease	0.00254	0.0029	CcSEcCtD
Donepezil—HTR2A—smooth muscle tissue—Crohn's disease	0.00253	0.0255	CbGeAlD
Donepezil—Weight decreased—Mesalazine—Crohn's disease	0.00253	0.00288	CcSEcCtD
Donepezil—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00253	0.00288	CcSEcCtD
Donepezil—Leukocytosis—Prednisone—Crohn's disease	0.00251	0.00286	CcSEcCtD
Donepezil—Pneumonia—Mesalazine—Crohn's disease	0.0025	0.00285	CcSEcCtD
Donepezil—Infestation NOS—Mesalazine—Crohn's disease	0.00249	0.00284	CcSEcCtD
Donepezil—Infestation—Mesalazine—Crohn's disease	0.00249	0.00284	CcSEcCtD
Donepezil—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00249	0.00284	CcSEcCtD
Donepezil—Depression—Mesalazine—Crohn's disease	0.00248	0.00283	CcSEcCtD
Donepezil—Cataract—Prednisone—Crohn's disease	0.00247	0.00282	CcSEcCtD
Donepezil—Haemoglobin—Azathioprine—Crohn's disease	0.00247	0.00281	CcSEcCtD
Donepezil—Haemorrhage—Azathioprine—Crohn's disease	0.00245	0.0028	CcSEcCtD
Donepezil—Renal failure—Mesalazine—Crohn's disease	0.00245	0.00279	CcSEcCtD
Donepezil—CYP2C9—digestive system—Crohn's disease	0.00243	0.0245	CbGeAlD
Donepezil—Jaundice—Mesalazine—Crohn's disease	0.00243	0.00277	CcSEcCtD
Donepezil—Urinary tract infection—Mesalazine—Crohn's disease	0.00242	0.00276	CcSEcCtD
Donepezil—Conjunctivitis—Mesalazine—Crohn's disease	0.00242	0.00276	CcSEcCtD
Donepezil—Sweating—Mesalazine—Crohn's disease	0.00239	0.00272	CcSEcCtD
Donepezil—Haematuria—Mesalazine—Crohn's disease	0.00237	0.00271	CcSEcCtD
Donepezil—Epistaxis—Mesalazine—Crohn's disease	0.00235	0.00268	CcSEcCtD
Donepezil—Body temperature increased—Mercaptopurine—Crohn's disease	0.00231	0.00264	CcSEcCtD
Donepezil—Haemoglobin—Mesalazine—Crohn's disease	0.00225	0.00256	CcSEcCtD
Donepezil—Rhinitis—Mesalazine—Crohn's disease	0.00224	0.00255	CcSEcCtD
Donepezil—Haemorrhage—Mesalazine—Crohn's disease	0.00224	0.00255	CcSEcCtD
Donepezil—Hepatitis—Mesalazine—Crohn's disease	0.00224	0.00255	CcSEcCtD
Donepezil—Pharyngitis—Mesalazine—Crohn's disease	0.00222	0.00253	CcSEcCtD
Donepezil—Urinary tract disorder—Mesalazine—Crohn's disease	0.00221	0.00252	CcSEcCtD
Donepezil—Oedema peripheral—Mesalazine—Crohn's disease	0.0022	0.00251	CcSEcCtD
Donepezil—Chills—Azathioprine—Crohn's disease	0.0022	0.00251	CcSEcCtD
Donepezil—Arrhythmia—Azathioprine—Crohn's disease	0.00219	0.0025	CcSEcCtD
Donepezil—Urethral disorder—Mesalazine—Crohn's disease	0.00219	0.0025	CcSEcCtD
Donepezil—Alopecia—Azathioprine—Crohn's disease	0.00217	0.00247	CcSEcCtD
Donepezil—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00216	0.00246	CcSEcCtD
Donepezil—Oesophagitis—Prednisone—Crohn's disease	0.00215	0.00245	CcSEcCtD
Donepezil—SIGMAR1—lymph node—Crohn's disease	0.00214	0.0216	CbGeAlD
Donepezil—Ecchymosis—Prednisone—Crohn's disease	0.00213	0.00243	CcSEcCtD
Donepezil—Tinnitus—Mesalazine—Crohn's disease	0.00208	0.00238	CcSEcCtD
Donepezil—Sepsis—Prednisone—Crohn's disease	0.00204	0.00233	CcSEcCtD
Donepezil—Euphoric mood—Prednisone—Crohn's disease	0.00202	0.00231	CcSEcCtD
Donepezil—Chills—Mesalazine—Crohn's disease	0.00201	0.00229	CcSEcCtD
Donepezil—Diarrhoea—Mercaptopurine—Crohn's disease	0.002	0.00228	CcSEcCtD
Donepezil—HTR2A—digestive system—Crohn's disease	0.002	0.0201	CbGeAlD
Donepezil—Ill-defined disorder—Azathioprine—Crohn's disease	0.00198	0.00226	CcSEcCtD
Donepezil—Alopecia—Mesalazine—Crohn's disease	0.00198	0.00225	CcSEcCtD
Donepezil—Anaemia—Azathioprine—Crohn's disease	0.00197	0.00225	CcSEcCtD
Donepezil—Diabetes mellitus—Prednisone—Crohn's disease	0.00197	0.00224	CcSEcCtD
Donepezil—Mental disorder—Mesalazine—Crohn's disease	0.00196	0.00223	CcSEcCtD
Donepezil—Erythema—Mesalazine—Crohn's disease	0.00195	0.00222	CcSEcCtD
Donepezil—Malaise—Azathioprine—Crohn's disease	0.00193	0.0022	CcSEcCtD
Donepezil—Flatulence—Mesalazine—Crohn's disease	0.00192	0.00219	CcSEcCtD
Donepezil—Tension—Mesalazine—Crohn's disease	0.00191	0.00218	CcSEcCtD
Donepezil—Dysgeusia—Mesalazine—Crohn's disease	0.00191	0.00217	CcSEcCtD
Donepezil—Nervousness—Mesalazine—Crohn's disease	0.00189	0.00215	CcSEcCtD
Donepezil—Cardiac failure congestive—Prednisone—Crohn's disease	0.00189	0.00215	CcSEcCtD
Donepezil—Back pain—Mesalazine—Crohn's disease	0.00188	0.00215	CcSEcCtD
Donepezil—Muscle spasms—Mesalazine—Crohn's disease	0.00187	0.00213	CcSEcCtD
Donepezil—Vomiting—Mercaptopurine—Crohn's disease	0.00186	0.00212	CcSEcCtD
Donepezil—Injury—Prednisone—Crohn's disease	0.00186	0.00212	CcSEcCtD
Donepezil—CYP3A4—digestive system—Crohn's disease	0.00185	0.0187	CbGeAlD
Donepezil—Rash—Mercaptopurine—Crohn's disease	0.00185	0.0021	CcSEcCtD
Donepezil—Dermatitis—Mercaptopurine—Crohn's disease	0.00184	0.0021	CcSEcCtD
Donepezil—Vision blurred—Mesalazine—Crohn's disease	0.00183	0.00209	CcSEcCtD
Donepezil—Tremor—Mesalazine—Crohn's disease	0.00182	0.00208	CcSEcCtD
Donepezil—CYP2D6—digestive system—Crohn's disease	0.00182	0.0184	CbGeAlD
Donepezil—Increased appetite—Prednisone—Crohn's disease	0.00182	0.00207	CcSEcCtD
Donepezil—Arthralgia—Azathioprine—Crohn's disease	0.00182	0.00207	CcSEcCtD
Donepezil—Myalgia—Azathioprine—Crohn's disease	0.00182	0.00207	CcSEcCtD
Donepezil—Ill-defined disorder—Mesalazine—Crohn's disease	0.00181	0.00206	CcSEcCtD
Donepezil—Anaemia—Mesalazine—Crohn's disease	0.0018	0.00205	CcSEcCtD
Donepezil—Discomfort—Azathioprine—Crohn's disease	0.0018	0.00205	CcSEcCtD
Donepezil—Malaise—Mesalazine—Crohn's disease	0.00176	0.002	CcSEcCtD
Donepezil—Cardiac failure—Prednisone—Crohn's disease	0.00175	0.002	CcSEcCtD
Donepezil—Vertigo—Mesalazine—Crohn's disease	0.00175	0.00199	CcSEcCtD
Donepezil—Syncope—Mesalazine—Crohn's disease	0.00175	0.00199	CcSEcCtD
Donepezil—Nausea—Mercaptopurine—Crohn's disease	0.00174	0.00198	CcSEcCtD
Donepezil—Infection—Azathioprine—Crohn's disease	0.00173	0.00197	CcSEcCtD
Donepezil—Loss of consciousness—Mesalazine—Crohn's disease	0.00171	0.00195	CcSEcCtD
Donepezil—Osteoarthritis—Prednisone—Crohn's disease	0.00171	0.00195	CcSEcCtD
Donepezil—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.00171	0.00195	CcSEcCtD
Donepezil—Thrombocytopenia—Azathioprine—Crohn's disease	0.00171	0.00195	CcSEcCtD
Donepezil—Cough—Mesalazine—Crohn's disease	0.0017	0.00194	CcSEcCtD
Donepezil—Affect lability—Prednisone—Crohn's disease	0.00168	0.00192	CcSEcCtD
Donepezil—Hypertension—Mesalazine—Crohn's disease	0.00168	0.00191	CcSEcCtD
Donepezil—Psychotic disorder—Prednisone—Crohn's disease	0.00167	0.0019	CcSEcCtD
Donepezil—Arthralgia—Mesalazine—Crohn's disease	0.00166	0.00189	CcSEcCtD
Donepezil—Myalgia—Mesalazine—Crohn's disease	0.00166	0.00189	CcSEcCtD
Donepezil—Chest pain—Mesalazine—Crohn's disease	0.00166	0.00189	CcSEcCtD
Donepezil—Anxiety—Mesalazine—Crohn's disease	0.00165	0.00188	CcSEcCtD
Donepezil—Face oedema—Prednisone—Crohn's disease	0.00165	0.00188	CcSEcCtD
Donepezil—Discomfort—Mesalazine—Crohn's disease	0.00164	0.00187	CcSEcCtD
Donepezil—Irritability—Prednisone—Crohn's disease	0.00163	0.00186	CcSEcCtD
Donepezil—Hypotension—Azathioprine—Crohn's disease	0.00163	0.00186	CcSEcCtD
Donepezil—Dry mouth—Mesalazine—Crohn's disease	0.00162	0.00185	CcSEcCtD
Donepezil—Mood swings—Prednisone—Crohn's disease	0.00162	0.00185	CcSEcCtD
Donepezil—Confusional state—Mesalazine—Crohn's disease	0.0016	0.00182	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00159	0.00181	CcSEcCtD
Donepezil—Oedema—Mesalazine—Crohn's disease	0.00159	0.00181	CcSEcCtD
Donepezil—Infection—Mesalazine—Crohn's disease	0.00158	0.0018	CcSEcCtD
Donepezil—Dry skin—Prednisone—Crohn's disease	0.00157	0.00179	CcSEcCtD
Donepezil—Shock—Mesalazine—Crohn's disease	0.00156	0.00178	CcSEcCtD
Donepezil—Nervous system disorder—Mesalazine—Crohn's disease	0.00156	0.00177	CcSEcCtD
Donepezil—Hypokalaemia—Prednisone—Crohn's disease	0.00156	0.00177	CcSEcCtD
Donepezil—Thrombocytopenia—Mesalazine—Crohn's disease	0.00156	0.00177	CcSEcCtD
Donepezil—Hyperhidrosis—Mesalazine—Crohn's disease	0.00154	0.00175	CcSEcCtD
Donepezil—Anorexia—Mesalazine—Crohn's disease	0.00151	0.00173	CcSEcCtD
Donepezil—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00151	0.00172	CcSEcCtD
Donepezil—Muscular weakness—Prednisone—Crohn's disease	0.00151	0.00172	CcSEcCtD
Donepezil—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00151	0.00172	CcSEcCtD
Donepezil—Abdominal distension—Prednisone—Crohn's disease	0.00149	0.0017	CcSEcCtD
Donepezil—Hypotension—Mesalazine—Crohn's disease	0.00148	0.00169	CcSEcCtD
Donepezil—Pancreatitis—Prednisone—Crohn's disease	0.00145	0.00165	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00145	0.00165	CcSEcCtD
Donepezil—Sweating increased—Prednisone—Crohn's disease	0.00144	0.00164	CcSEcCtD
Donepezil—Feeling abnormal—Azathioprine—Crohn's disease	0.00144	0.00164	CcSEcCtD
Donepezil—Insomnia—Mesalazine—Crohn's disease	0.00144	0.00164	CcSEcCtD
Donepezil—Paraesthesia—Mesalazine—Crohn's disease	0.00143	0.00163	CcSEcCtD
Donepezil—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00143	0.00162	CcSEcCtD
Donepezil—Dyspnoea—Mesalazine—Crohn's disease	0.00142	0.00161	CcSEcCtD
Donepezil—Somnolence—Mesalazine—Crohn's disease	0.00141	0.00161	CcSEcCtD
Donepezil—Dyspepsia—Mesalazine—Crohn's disease	0.0014	0.00159	CcSEcCtD
Donepezil—Decreased appetite—Mesalazine—Crohn's disease	0.00138	0.00157	CcSEcCtD
Donepezil—Abdominal pain—Azathioprine—Crohn's disease	0.00138	0.00157	CcSEcCtD
Donepezil—Body temperature increased—Azathioprine—Crohn's disease	0.00138	0.00157	CcSEcCtD
Donepezil—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00137	0.00156	CcSEcCtD
Donepezil—Fatigue—Mesalazine—Crohn's disease	0.00137	0.00156	CcSEcCtD
Donepezil—Constipation—Mesalazine—Crohn's disease	0.00136	0.00155	CcSEcCtD
Donepezil—Pain—Mesalazine—Crohn's disease	0.00136	0.00155	CcSEcCtD
Donepezil—Weight increased—Prednisone—Crohn's disease	0.00134	0.00153	CcSEcCtD
Donepezil—Weight decreased—Prednisone—Crohn's disease	0.00134	0.00152	CcSEcCtD
Donepezil—Hyperglycaemia—Prednisone—Crohn's disease	0.00133	0.00152	CcSEcCtD
Donepezil—Depression—Prednisone—Crohn's disease	0.00131	0.0015	CcSEcCtD
Donepezil—Feeling abnormal—Mesalazine—Crohn's disease	0.00131	0.00149	CcSEcCtD
Donepezil—Acute coronary syndrome—Prednisone—Crohn's disease	0.0013	0.00148	CcSEcCtD
Donepezil—Gastrointestinal pain—Mesalazine—Crohn's disease	0.0013	0.00148	CcSEcCtD
Donepezil—Myocardial infarction—Prednisone—Crohn's disease	0.00129	0.00147	CcSEcCtD
Donepezil—Hypersensitivity—Azathioprine—Crohn's disease	0.00128	0.00146	CcSEcCtD
Donepezil—Urticaria—Mesalazine—Crohn's disease	0.00126	0.00144	CcSEcCtD
Donepezil—Abdominal pain—Mesalazine—Crohn's disease	0.00126	0.00143	CcSEcCtD
Donepezil—Body temperature increased—Mesalazine—Crohn's disease	0.00126	0.00143	CcSEcCtD
Donepezil—Bradycardia—Prednisone—Crohn's disease	0.0012	0.00137	CcSEcCtD
Donepezil—Diarrhoea—Azathioprine—Crohn's disease	0.00119	0.00136	CcSEcCtD
Donepezil—Haemoglobin—Prednisone—Crohn's disease	0.00119	0.00135	CcSEcCtD
Donepezil—Haemorrhage—Prednisone—Crohn's disease	0.00118	0.00135	CcSEcCtD
Donepezil—Hallucination—Prednisone—Crohn's disease	0.00118	0.00134	CcSEcCtD
Donepezil—Hypersensitivity—Mesalazine—Crohn's disease	0.00117	0.00133	CcSEcCtD
Donepezil—Dizziness—Azathioprine—Crohn's disease	0.00115	0.00131	CcSEcCtD
Donepezil—Asthenia—Mesalazine—Crohn's disease	0.00114	0.0013	CcSEcCtD
Donepezil—Pruritus—Mesalazine—Crohn's disease	0.00112	0.00128	CcSEcCtD
Donepezil—Vomiting—Azathioprine—Crohn's disease	0.00111	0.00126	CcSEcCtD
Donepezil—Rash—Azathioprine—Crohn's disease	0.0011	0.00125	CcSEcCtD
Donepezil—Dermatitis—Azathioprine—Crohn's disease	0.0011	0.00125	CcSEcCtD
Donepezil—Headache—Azathioprine—Crohn's disease	0.00109	0.00124	CcSEcCtD
Donepezil—Diarrhoea—Mesalazine—Crohn's disease	0.00109	0.00124	CcSEcCtD
Donepezil—Arrhythmia—Prednisone—Crohn's disease	0.00106	0.0012	CcSEcCtD
Donepezil—Dizziness—Mesalazine—Crohn's disease	0.00105	0.0012	CcSEcCtD
Donepezil—Alopecia—Prednisone—Crohn's disease	0.00105	0.00119	CcSEcCtD
Donepezil—Mental disorder—Prednisone—Crohn's disease	0.00104	0.00118	CcSEcCtD
Donepezil—Nausea—Azathioprine—Crohn's disease	0.00104	0.00118	CcSEcCtD
Donepezil—Erythema—Prednisone—Crohn's disease	0.00103	0.00117	CcSEcCtD
Donepezil—Malnutrition—Prednisone—Crohn's disease	0.00103	0.00117	CcSEcCtD
Donepezil—Vomiting—Mesalazine—Crohn's disease	0.00101	0.00115	CcSEcCtD
Donepezil—Rash—Mesalazine—Crohn's disease	0.001	0.00114	CcSEcCtD
Donepezil—Dermatitis—Mesalazine—Crohn's disease	0.001	0.00114	CcSEcCtD
Donepezil—Headache—Mesalazine—Crohn's disease	0.000995	0.00113	CcSEcCtD
Donepezil—Vision blurred—Prednisone—Crohn's disease	0.00097	0.00111	CcSEcCtD
Donepezil—Ill-defined disorder—Prednisone—Crohn's disease	0.000955	0.00109	CcSEcCtD
Donepezil—Anaemia—Prednisone—Crohn's disease	0.000952	0.00108	CcSEcCtD
Donepezil—Agitation—Prednisone—Crohn's disease	0.000946	0.00108	CcSEcCtD
Donepezil—Nausea—Mesalazine—Crohn's disease	0.000943	0.00108	CcSEcCtD
Donepezil—Malaise—Prednisone—Crohn's disease	0.000929	0.00106	CcSEcCtD
Donepezil—Vertigo—Prednisone—Crohn's disease	0.000925	0.00105	CcSEcCtD
Donepezil—Syncope—Prednisone—Crohn's disease	0.000923	0.00105	CcSEcCtD
Donepezil—HTR2A—Serotonin Receptor 2 and STAT3 Signaling—JAK2—Crohn's disease	0.000907	0.0392	CbGpPWpGaD
Donepezil—Loss of consciousness—Prednisone—Crohn's disease	0.000905	0.00103	CcSEcCtD
Donepezil—Convulsion—Prednisone—Crohn's disease	0.000892	0.00102	CcSEcCtD
Donepezil—Hypertension—Prednisone—Crohn's disease	0.000889	0.00101	CcSEcCtD
Donepezil—Arthralgia—Prednisone—Crohn's disease	0.000877	0.000999	CcSEcCtD
Donepezil—Myalgia—Prednisone—Crohn's disease	0.000877	0.000999	CcSEcCtD
Donepezil—Anxiety—Prednisone—Crohn's disease	0.000874	0.000995	CcSEcCtD
Donepezil—Discomfort—Prednisone—Crohn's disease	0.000866	0.000987	CcSEcCtD
Donepezil—Oedema—Prednisone—Crohn's disease	0.00084	0.000958	CcSEcCtD
Donepezil—Infection—Prednisone—Crohn's disease	0.000835	0.000951	CcSEcCtD
Donepezil—Shock—Prednisone—Crohn's disease	0.000827	0.000942	CcSEcCtD
Donepezil—Nervous system disorder—Prednisone—Crohn's disease	0.000824	0.000939	CcSEcCtD
Donepezil—Hyperhidrosis—Prednisone—Crohn's disease	0.000812	0.000926	CcSEcCtD
Donepezil—Anorexia—Prednisone—Crohn's disease	0.000801	0.000913	CcSEcCtD
Donepezil—ACHE—ATF-2 transcription factor network—IL23A—Crohn's disease	0.000798	0.0345	CbGpPWpGaD
Donepezil—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000766	0.000872	CcSEcCtD
Donepezil—Insomnia—Prednisone—Crohn's disease	0.00076	0.000866	CcSEcCtD
Donepezil—Paraesthesia—Prednisone—Crohn's disease	0.000755	0.00086	CcSEcCtD
Donepezil—Dyspepsia—Prednisone—Crohn's disease	0.00074	0.000843	CcSEcCtD
Donepezil—Decreased appetite—Prednisone—Crohn's disease	0.000731	0.000832	CcSEcCtD
Donepezil—Fatigue—Prednisone—Crohn's disease	0.000725	0.000826	CcSEcCtD
Donepezil—Constipation—Prednisone—Crohn's disease	0.000719	0.000819	CcSEcCtD
Donepezil—Feeling abnormal—Prednisone—Crohn's disease	0.000693	0.000789	CcSEcCtD
Donepezil—Gastrointestinal pain—Prednisone—Crohn's disease	0.000687	0.000783	CcSEcCtD
Donepezil—Urticaria—Prednisone—Crohn's disease	0.000668	0.000761	CcSEcCtD
Donepezil—HTR2A—Serotonin Receptor 2 and STAT3 Signaling—STAT3—Crohn's disease	0.000665	0.0288	CbGpPWpGaD
Donepezil—Abdominal pain—Prednisone—Crohn's disease	0.000664	0.000757	CcSEcCtD
Donepezil—Body temperature increased—Prednisone—Crohn's disease	0.000664	0.000757	CcSEcCtD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.000636	0.0275	CbGpPWpGaD
Donepezil—ACHE—Glycerophospholipid biosynthesis—PLA2G4F—Crohn's disease	0.000624	0.027	CbGpPWpGaD
Donepezil—Hypersensitivity—Prednisone—Crohn's disease	0.000619	0.000706	CcSEcCtD
Donepezil—Asthenia—Prednisone—Crohn's disease	0.000603	0.000687	CcSEcCtD
Donepezil—Pruritus—Prednisone—Crohn's disease	0.000595	0.000677	CcSEcCtD
Donepezil—Diarrhoea—Prednisone—Crohn's disease	0.000575	0.000655	CcSEcCtD
Donepezil—Dizziness—Prednisone—Crohn's disease	0.000556	0.000633	CcSEcCtD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.000545	0.0235	CbGpPWpGaD
Donepezil—Vomiting—Prednisone—Crohn's disease	0.000534	0.000609	CcSEcCtD
Donepezil—Rash—Prednisone—Crohn's disease	0.00053	0.000604	CcSEcCtD
Donepezil—Dermatitis—Prednisone—Crohn's disease	0.000529	0.000603	CcSEcCtD
Donepezil—Headache—Prednisone—Crohn's disease	0.000526	0.0006	CcSEcCtD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.000516	0.0223	CbGpPWpGaD
Donepezil—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—RASGRP1—Crohn's disease	0.000514	0.0222	CbGpPWpGaD
Donepezil—Nausea—Prednisone—Crohn's disease	0.000499	0.000569	CcSEcCtD
Donepezil—HRH3—Monoamine Transport—IL1B—Crohn's disease	0.000454	0.0196	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—CCR9—Crohn's disease	0.00045	0.0195	CbGpPWpGaD
Donepezil—ACHE—Phospholipid metabolism—PLA2G4F—Crohn's disease	0.000435	0.0188	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.000418	0.0181	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—ACKR2—Crohn's disease	0.000415	0.0179	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—MLN—Crohn's disease	0.000393	0.017	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000388	0.0168	CbGpPWpGaD
Donepezil—ACHE—Phospholipid metabolism—MTMR3—Crohn's disease	0.00037	0.016	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000358	0.0155	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000333	0.0144	CbGpPWpGaD
Donepezil—HRH3—Monoamine Transport—TNF—Crohn's disease	0.00033	0.0143	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000312	0.0135	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—CCR6—Crohn's disease	0.000298	0.0129	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000277	0.012	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CREM—Crohn's disease	0.000273	0.0118	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—CCR9—Crohn's disease	0.000273	0.0118	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—MLN—Crohn's disease	0.000258	0.0112	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—GPR65—Crohn's disease	0.000253	0.011	CbGpPWpGaD
Donepezil—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000247	0.0107	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000244	0.0105	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000237	0.0103	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.000231	0.00998	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—MLN—Crohn's disease	0.000222	0.00961	CbGpPWpGaD
Donepezil—ACHE—Monoamine Transport—IL1B—Crohn's disease	0.000217	0.0094	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—ACKR2—Crohn's disease	0.000213	0.0092	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00021	0.0091	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000209	0.00902	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—MLN—Crohn's disease	0.000202	0.00872	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—CCR6—Crohn's disease	0.000181	0.00781	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00018	0.0078	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—SBSPON—Crohn's disease	0.000175	0.00755	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.000171	0.00739	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—GPR65—Crohn's disease	0.000166	0.00719	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—PTGER4—Crohn's disease	0.000159	0.00687	CbGpPWpGaD
Donepezil—ACHE—Monoamine Transport—TNF—Crohn's disease	0.000158	0.00682	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—CCR9—Crohn's disease	0.000154	0.00666	CbGpPWpGaD
Donepezil—ACHE—ATF-2 transcription factor network—IFNG—Crohn's disease	0.000149	0.00646	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.000149	0.00643	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—GPR65—Crohn's disease	0.000143	0.00619	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00014	0.00606	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—CCR9—Crohn's disease	0.00014	0.00605	CbGpPWpGaD
Donepezil—ACHE—ATF-2 transcription factor network—CXCL8—Crohn's disease	0.000139	0.00601	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.000138	0.00598	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—ACKR2—Crohn's disease	0.000137	0.00594	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—MLN—Crohn's disease	0.00013	0.00563	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—GPR65—Crohn's disease	0.00013	0.00562	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000129	0.00556	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000126	0.00546	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ACKR2—Crohn's disease	0.000126	0.00544	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MLN—Crohn's disease	0.000119	0.00515	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000119	0.00515	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000118	0.00512	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00011	0.00476	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TAGAP—Crohn's disease	0.000109	0.00471	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—CCR6—Crohn's disease	0.000102	0.00441	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—CXCL8—Crohn's disease	9.61e-05	0.00415	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RSPO3—Crohn's disease	9.53e-05	0.00412	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	9.28e-05	0.00401	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—CCR6—Crohn's disease	9.26e-05	0.00401	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	9.16e-05	0.00396	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	9.15e-05	0.00396	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	9.07e-05	0.00392	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SEL1L—Crohn's disease	9.03e-05	0.00391	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CCR9—Crohn's disease	9.02e-05	0.0039	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—PTGER4—Crohn's disease	8.98e-05	0.00388	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	8.69e-05	0.00376	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—RASGRP1—Crohn's disease	8.6e-05	0.00372	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—GPR65—Crohn's disease	8.39e-05	0.00363	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CCR9—Crohn's disease	8.26e-05	0.00357	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—PTGER4—Crohn's disease	8.16e-05	0.00353	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL10—Crohn's disease	8.07e-05	0.00349	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	8.07e-05	0.00349	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	7.85e-05	0.00339	CbGpPWpGaD
Donepezil—ACHE—ATF-2 transcription factor network—IL6—Crohn's disease	7.8e-05	0.00337	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	7.69e-05	0.00332	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—GPR65—Crohn's disease	7.68e-05	0.00332	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—IL3—Crohn's disease	7.65e-05	0.00331	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	7.64e-05	0.0033	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—RASGRP1—Crohn's disease	7.4e-05	0.0032	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—MLN—Crohn's disease	7.36e-05	0.00318	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—ACKR2—Crohn's disease	7.05e-05	0.00305	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—IL3—Crohn's disease	6.95e-05	0.003	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	6.91e-05	0.00299	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—RASGRP1—Crohn's disease	6.72e-05	0.00291	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—MLN—Crohn's disease	6.68e-05	0.00289	CbGpPWpGaD
Donepezil—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	6.65e-05	0.00287	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PLA2G4F—Crohn's disease	6.24e-05	0.0027	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	5.98e-05	0.00259	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CCR6—Crohn's disease	5.98e-05	0.00258	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—CXCL8—Crohn's disease	5.82e-05	0.00252	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	5.7e-05	0.00246	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	5.6e-05	0.00242	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CCR6—Crohn's disease	5.47e-05	0.00237	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—IL2RA—Crohn's disease	5.36e-05	0.00232	CbGpPWpGaD
Donepezil—ACHE—Metabolism—MTMR3—Crohn's disease	5.3e-05	0.00229	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—PTGER4—Crohn's disease	5.26e-05	0.00228	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CCR9—Crohn's disease	5.1e-05	0.0022	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RBX1—Crohn's disease	4.95e-05	0.00214	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—IL2RA—Crohn's disease	4.87e-05	0.0021	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4.84e-05	0.00209	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PTGER4—Crohn's disease	4.82e-05	0.00208	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—GPR65—Crohn's disease	4.74e-05	0.00205	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCR9—Crohn's disease	4.63e-05	0.002	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	4.41e-05	0.00191	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—UBE2D1—Crohn's disease	4.34e-05	0.00188	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—GPR65—Crohn's disease	4.3e-05	0.00186	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	4.24e-05	0.00183	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RIPK2—Crohn's disease	4.21e-05	0.00182	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ACKR2—Crohn's disease	4.16e-05	0.0018	CbGpPWpGaD
Donepezil—ACHE—Metabolism—FADS1—Crohn's disease	4.13e-05	0.00179	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL3—Crohn's disease	4.1e-05	0.00177	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RASGRP1—Crohn's disease	3.97e-05	0.00172	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MLN—Crohn's disease	3.95e-05	0.00171	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	3.92e-05	0.0017	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GPX4—Crohn's disease	3.87e-05	0.00167	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.78e-05	0.00163	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.77e-05	0.00163	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	3.74e-05	0.00162	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GCKR—Crohn's disease	3.74e-05	0.00162	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TAGAP—Crohn's disease	3.61e-05	0.00156	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—JAK2—Crohn's disease	3.6e-05	0.00156	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SOCS1—Crohn's disease	3.6e-05	0.00155	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.53e-05	0.00153	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—TYK2—Crohn's disease	3.43e-05	0.00148	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CCR6—Crohn's disease	3.38e-05	0.00146	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—CXCL8—Crohn's disease	3.29e-05	0.00142	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—JAK2—Crohn's disease	3.27e-05	0.00141	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RSPO3—Crohn's disease	3.15e-05	0.00136	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SMAD3—Crohn's disease	3.1e-05	0.00134	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—TNF—Crohn's disease	3.07e-05	0.00133	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCR6—Crohn's disease	3.07e-05	0.00133	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SEL1L—Crohn's disease	2.99e-05	0.00129	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—CXCL8—Crohn's disease	2.99e-05	0.00129	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PTGER4—Crohn's disease	2.97e-05	0.00129	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL2RA—Crohn's disease	2.87e-05	0.00124	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCR9—Crohn's disease	2.74e-05	0.00118	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PTGER4—Crohn's disease	2.7e-05	0.00117	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.67e-05	0.00115	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	2.56e-05	0.00111	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GPR65—Crohn's disease	2.54e-05	0.0011	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	2.54e-05	0.0011	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—IL3—Crohn's disease	2.53e-05	0.0011	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	2.53e-05	0.00109	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL6—Crohn's disease	2.48e-05	0.00107	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—RASGRP1—Crohn's disease	2.45e-05	0.00106	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.34e-05	0.00101	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL3—Crohn's disease	2.3e-05	0.000995	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—RASGRP1—Crohn's disease	2.22e-05	0.000962	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MTMR3—Crohn's disease	2.18e-05	0.000941	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MTMR3—Crohn's disease	2.16e-05	0.000933	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TYK2—Crohn's disease	2.03e-05	0.000876	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—CXCL8—Crohn's disease	1.96e-05	0.000847	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—JAK2—Crohn's disease	1.93e-05	0.000836	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CXCL8—Crohn's disease	1.93e-05	0.000833	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	1.92e-05	0.00083	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCR6—Crohn's disease	1.81e-05	0.000783	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—IL2RA—Crohn's disease	1.77e-05	0.000767	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CXCL8—Crohn's disease	1.76e-05	0.000763	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—FADS1—Crohn's disease	1.7e-05	0.000733	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—FADS1—Crohn's disease	1.68e-05	0.000727	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—IL6—Crohn's disease	1.68e-05	0.000725	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.67e-05	0.000723	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RBX1—Crohn's disease	1.64e-05	0.000709	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	1.61e-05	0.000697	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	1.6e-05	0.00069	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GPX4—Crohn's disease	1.59e-05	0.000686	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GPX4—Crohn's disease	1.57e-05	0.00068	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GCKR—Crohn's disease	1.53e-05	0.000663	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GCKR—Crohn's disease	1.52e-05	0.000657	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	1.44e-05	0.000621	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.42e-05	0.000615	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—STAT3—Crohn's disease	1.42e-05	0.000613	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	1.39e-05	0.000602	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL3—Crohn's disease	1.36e-05	0.000587	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	1.31e-05	0.000568	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	1.19e-05	0.000516	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	1.19e-05	0.000515	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ALB—Crohn's disease	1.19e-05	0.000514	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	1.14e-05	0.000491	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—FADS1—Crohn's disease	1.11e-05	0.000479	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	1.09e-05	0.000471	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.09e-05	0.00047	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	1.08e-05	0.000468	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS2—Crohn's disease	1.04e-05	0.00045	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GPX4—Crohn's disease	1.04e-05	0.000449	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	1.03e-05	0.000444	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GCKR—Crohn's disease	1e-05	0.000433	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL6—Crohn's disease	9.91e-06	0.000428	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	9.88e-06	0.000427	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	9.52e-06	0.000412	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	9.5e-06	0.000411	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TYK2—Crohn's disease	6.71e-06	0.00029	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JAK2—Crohn's disease	6.4e-06	0.000277	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	5.84e-06	0.000252	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6—Crohn's disease	5.55e-06	0.00024	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALB—Crohn's disease	4.88e-06	0.000211	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALB—Crohn's disease	4.84e-06	0.000209	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STAT3—Crohn's disease	4.7e-06	0.000203	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS2—Crohn's disease	4.27e-06	0.000185	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS2—Crohn's disease	4.23e-06	0.000183	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6—Crohn's disease	3.28e-06	0.000142	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALB—Crohn's disease	3.19e-06	0.000138	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.79e-06	0.000121	CbGpPWpGaD
